Suzhou Basecare Medical’s BKA210 Receives Marketing Approval in Jiangsu Province
China-based in vitro fertilization (IVF) specialist Suzhou Basecare Medical Co., Ltd (HKG: 2170) has announced...
Product approvals
Humanwell Healthcare Receives NMPA Approval for Compound Sodium Lactate Ringer’s Injection
Humanwell Healthcare (Group) Co., Ltd (SHA: 600079) has received approval from the National Medical Products...
CStone Pharmaceuticals’ Sugemalimab Wins UK Approval for NSCLC Treatment
China-based CStone Pharmaceuticals (HKG: 2616) has received marketing approval from the UK Medicines and Healthcare...
AbbVie’s Allergan Aesthetics Launches Juvéderm VOLUX in China
Allergan Aesthetics, a subsidiary of AbbVie (NYSE: ABBV), has announced the official market launch of...
Acotec Secures NMPA Approval for Acotrace Disposable Catheter Sheath
Acotec Scientific Holdings Ltd (HKG: 6669), based in China, has received marketing approval from the...
Novartis Secures FDA Accelerated Approval for Scemblix in Newly Diagnosed CML Patients
Swiss pharmaceutical giant Novartis (NYSE: NVS) announced that its drug Scemblix (asciminib) has received accelerated...
Xi’an Xintong Pharma’s Pradefavir Wins NMPA Nod for Chronic Hepatitis B Treatment
The National Medical Products Administration (NMPA) has granted market approval for pradefavir, a Category 1...
Eli Lilly’s Mounjaro Approved in Hong Kong for Obesity and Type 2 Diabetes Treatment
Eli Lilly & Co. (NYSE: LLY) has received market approval from Hong Kong’s Department of...
Merck’s Keytruda Gains Two Additional EU Indications for Gynecologic Cancer Treatment
Merck, Sharp & Dohme Inc., known as MSD (NYSE: MRK), has received two additional indication...
AstraZeneca’s Fasenra Approved by EU for Eosinophilic Granulomatosis Treatment
UK pharmaceutical giant AstraZeneca Inc. (NASDAQ: AZN) has received marketing approval from the European Commission...
AstraZeneca’s Zoladex Receives NMPA Approval for Higher Dosage Form in Breast Cancer Treatment
AstraZeneca Inc., (AZ, NASDAQ: AZN), a UK-based pharmaceutical giant, has announced that it has received...
Wantai Biological’s P85 Ab Detection Kit Receives NMPA Approval for Nasopharyngeal Carcinoma Screening
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd (SHA: 603392), a Chinese pharmaceutical company, announced last...
Zhuhai Beihai Biotech’s Beizary Receives FDA Clearance for Multiple Cancer Indications
Zhuhai Beihai Biotech Co., Ltd has announced that it has received marketing clearance from the...
Chongqing Zhifei Biological’s Influenza Vaccine Application Accepted by China’s Drug Evaluation Center
On October 24, 2024, the Center for Drug Evaluation of the National Medical Products Administration...
Eli Lilly’s Alzheimer’s Drug Kisunla Secures Marketing Approval in Great Britain
Eli Lilly & Co. (NYSE: LLY) has announced that it has received marketing approval in...
Sino Medical Sciences Technology Secures Marketing Approval for Coronary Balloon Dilation Catheter in Morocco
Sino Medical Sciences Technology Inc., (SHA: 688108) a China-based medical device company, has announced that...
China Grand Pharmaceutical Receives NMPA Approval for Innovative Adjustable Thrombectomy Stent
China Grand Pharmaceutical and Healthcare Holdings Ltd (CGP; HKG: 0512) has announced that it has...
Walvax Biotechnology’s Weuphoria Vaccine Approved in Oman for Pediatric Pneumococcal Infections
Walvax Biotechnology Co., Ltd (SHE: 300142), a Chinese biopharmaceutical company, has announced that it has...
German Endoscope Maker KARL STORZ Secures Marketing Approval for Disposable Ureteroscope in China
KARL STORZ SE & Co. KG, a leading German endoscope manufacturer, has announced that it...
Thermo Fisher’s Oncomine Dx Target Test Gets FDA Green Light as Companion Diagnostic for Servier’s Voranigo
US pharmaceutical and biotechnology company Thermo Fisher Scientific (NYSE: TMO) has received marketing approval from...